Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives.

Genentech, Inc. (Genentech) is a biotechnology company that discovers, develops, manufactures and commercializes pharmaceutical products to treat patients with unmet medical needs. It commercializes multiple biotechnology products and also receives royalties from companies that are... more

Lorus Therapeutics Inc. (Lorus) is a life sciences company focused on the discovery, research and development of anticancer therapies. The Company has worked to establish a diverse anticancer product pipeline, with products in various stages of development ranging from pre-clinical to an... more

Celgene Corporation is an integrated biopharmaceutical company. The Company is primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. The Company’s lead product is REVLIMID (lenalidomide) and... more

Myriad Genetics, Inc. is a healthcare company focused on the development and marketing of molecular diagnostic and therapeutic products. The Company’s molecular diagnostic business focuses on the analysis of genes and their alterations to assess an individual’s risk for developing disease... more

YM BioSciences Inc. (YM BioSciences) is engaged in the licensing and commercialization of drug products and technologies from original research. The Company is advancing two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor... more

Antisoma plc (Antisoma) is a United Kingdom-based biopharmaceutical company, focused on developing products for the treatment of cancer. The Company has a portfolio of drugs in development, including small molecules, antibody-based therapies and a deoxyribonucleic acid (DNA) aptamer.... more

Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that harness the immune system to fight cancer. Dendreon’s most advanced product candidate is Provenge (sipuleucel-T), an active cellular immunotherapy... more

Coley Pharmaceutical was founded in 1997 to pursue a single goal: to develop biopharmaceuticals that build on the pioneering science of TLR stimulation to direct targeted immune responses that fight diseases. Our proprietary TLR TherapeuticsÔ drug platform is based on ground-breaking... more

MGI PHARMA, INC. is a biopharmaceutical company focused in oncology and acute care that acquires, researches, develops, and commercializes proprietary products that address the unmet needs of patients. MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) Injection, Dacogen(R)... more

Cytogen Corporation of Princeton, NJ is a product-driven, oncology-focused biopharmaceutical company. Cytogen markets proprietary and licensed oncology products through its in-house specialty sales force: Quadramet® (a skeletal targeting therapeutic radiopharmaceutical for the relief of... more

SuperGen, Inc. is a pharmaceutical company dedicated primarily to the discovery, development and commercialization of therapies to treat patients with cancer. The Company acquires products that were developed by other companies and applies additional developmental effort to expand sales... more

Cyclacel is a biopharmaceutical company that designs and develops small molecule drugs that act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. The Company's discovery engines integrate cell cycle biology... more

Protherics is a leading biopharmaceutical company focused on developing, manufacturing and marketing critical care and cancer products. We have developed two FDA approved products in-house, CroFabÔ and DigiFabÔ. Our plan is to use revenues from our marketed products and licensing income... more

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes... more

NeoRx is a cancer therapeutics development company dedicated to the development and commercialization of oncology products that impact the lives of individuals afflicted with cancer and metastases. The Company currently is focusing its development efforts on picoplatin, a... more

ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company’s lead products, which are in clinical-stage testing, consist of ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase; ARQ 501, an... more

Genta Incorporated (Genta) is a biopharmaceutical company engaged in pharmaceutical (drug) research and development. The Company focuses on the identification, development and commercialization of drugs for the treatment of cancer and related diseases. Genta’s research portfolio consists... more

Poniard Pharmaceuticals Inc. (Poniard) is a biopharmaceutical company focused on the development and commercialization of cancer therapy products. Its lead product candidate is picoplatin, a new generation platinum-based cancer therapy with an improved safety profile. An intravenous... more

Pro-Pharmaceuticals, Inc. is a development stage company engaged in the discovery, development, and commercialization of first-in-class, targeted therapeutic compounds for advanced treatment of cancer, liver, microbial and inflammatory diseases. The Company focuses on the development of a... more

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The Company is developing product candidates to treat a range of cancers using tumor... more

Seattle Genetics, Inc. is a clinical-stage biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The Company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize the product candidate... more

Bradmer Pharmaceuticals Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of new cancer therapies. The Company's first product candidate, Neuradiab, represents an advance in the treatment of certain brain cancers. As of December 31, 2007,... more

Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company has three active independent development programs in the areas of infectious disease and... more

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect... more

Onyvax is developing new cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells. Onyvax's products specifically target cancer cells, increasing the likelihood that they will be effective while minimising side effects associated with many... more

Palatin Technologies, Inc. is a biopharmaceutical company engaged in the development of peptide, peptide mimetic and small molecule compounds with a focus on melanocortin and natriuretic peptide receptor systems. As of June 30, 2008, the Company's products under development included... more

Novacea, Inc. (Novacea) is a biopharmaceutical company focused on in-licensing, developing and commercializing therapies for the treatment of cancer. The Company’s product portfolio features two clinical-stage oncology product candidates with worldwide rights, Asentar and AQ4N, each of... more

Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors as treatments for patients living with cancer. The Company has three product candidates, for which it has exclusive worldwide... more

CEL-SCI Corporation is engaged in the development of a product called Multikine for the treatment of cancer. It simulates the activities of a healthy person's immune system, which battles cancer every day. Multikine is multi-targeted, it is the cancer immunotherapy that both kills cancer... more

Provectus Pharmaceuticals, Inc. (Provectus) develops, licenses and markets and plans to sell products in three sectors of the healthcare industry, which include Over-the-counter products (OTC products), Prescription drugs, and Medical device systems. The Company conducts its business... more

BiPar Sciences is a privately held biopharmaceutical company committed to creating a world-class drug development and commercialization organization that addresses significant unmet medical needs in oncology. Our lead product candidate is BSI-201, which is now in a Phase 1a trial as a... more

Oncolytics Biotech Inc. is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is in the research and... more

Ortho Biotech Products, L.P. is a leading biopharmaceutical company that provides innovative products and services designed to help enhance the lives of individuals with serious chronic illnesses. Following more than a decade of research and clinical practice, Ortho Biotech and its... more

Procyon Biopharma (Procyon) is a biotechnology company actively engaged in the development of innovative therapeutics in the fields of cancer and HIV/AIDS. The Company leverages its strengths in clinical research and development, bringing products through early- to mid-stage clinical... more

IDEC is a leader in the discovery, development, and commercialization of targeted immunotherapies for the treatment of cancer and autoimmune diseases. IDEC discovered and developed the first commercially available radioimmunotherapy product (Zevalin®) approved in the United States, which... more

Nuvelo, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. The Company’s development pipeline includes alfimeprase, a direct-acting fibrinolytic in... more

Onyx Pharmaceuticals, Inc. (Onyx) is a biopharmaceutical company engaged in developing therapies that target the molecular mechanisms that cause cancer. With the Company’s collaborators, the Company is developing small molecule drugs. The Company develops oral anticancer therapies... more

Genitope Corporation is a development-stage enterprise focused on the research and development of immunotherapies for the treatment of cancer. Until the recent suspension of the development program, the Company's lead product candidate was MyVax personalized immunotherapy (MyVax),... more

BioMS Medical Corp. (BioMS) is a biotechnology company engaged in the development and commercialization of therapeutic technologies for the treatment of multiple sclerosis (MS). During the year ended December 31, 2007, BioMS conducted a number of clinical trials with MBP8298: two pivotal... more

Caprion offers its employees a dynamic and stimulating work environment, encouraging continuous innovation and the sharing of knowledge and ideas. We offer a comprehensive compensation package, including a competitive salary, participation in an employee stock option plan, a group... more

We are committed to improving therapy for cancer patients by building strong international collaborations to fully realize the potential of our products. On 31st Jan 2006, KuDOS was aquired and is now a wholly owned subsidiary of AstraZeneca.

GammaCan International, Inc. (GammaCan) is a life science company focused on the development of immunotherapy and related approaches to treat cancer. The Company has focused on the use of intravenous immunoglobulins, (IgGs), derived from human plasma to treat melanoma, and other cancers.... more

TopoTarget A/S is a Denmark-based biotech company. It is focused on treatments for cancer patients and other cancer-related disorders. Its activities cover various aspects of drug development, including assay development, screening, biology, medicinal chemistry, preclinical and clinical... more

OncoVista is a development-stage pharmaceutical company dedicated to providing innovative, safe and efficacious treatments for cancer.

At Semafore we are dedicated to discovering and developing the next generation of novel cancer therapeutics. Semafore currently employs over 20 people and is headquartered in Indianapolis, Indiana --home of the famous Indy 500 and leading a growing life sciences environment in the State.... more

Helix BioPharma Corp. is a Canada-based biopharmaceutical company developing products for the treatment of cancer and prevention of cancer. Its revenue consists of product revenue, including the distribution in Canada of Klean-Prep and Orthovisc, and royalty payments from Helsinn-Birex... more

Cell Therapeutics, Inc. develops, acquires and commercializes treatments for cancer. The Company’s research, development, acquisition and in-licensing activities concentrate on identifying and developing new, less toxic and effective ways to treat cancer. It is developing paclitaxel... more

Biotherapies is focused on the development of Mammastatin, a growth inhibitory protein that is being commercialized as a potential therapy for breast cancer.

OncoGenex is a private biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. The company's three product candidates are designed to inhibit the production of specific proteins associated... more